KDIGO guidelines include FILSPARI for IgA nephropathy treatment
Go back to KDIGO guidelines include FILSPARI for IgA nephropathy treatment| CARLISLE COMPANIES, Inc. (NYSE: CSL) | Delayed: 354.56 -20.22 (5.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $374.78 | 52 Week High | $114.49 | |||
| Open | $364.87 | 52 Week Low | $75.17 | |||
| Day High | $365.52 | P/E | 98.22 | |||
| Day Low | $350.69 | EPS | $3.61 | |||
| Volume | 451,915 | |||||
| (AMEX: CSLLY) | Delayed: 25.15 -0.26 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.41 | 52 Week High | $45.60 | |||
| Open | $25.13 | 52 Week Low | $33.39 | |||
| Day High | $25.50 | P/E | N/A | |||
| Day Low | $25.05 | EPS | $0.00 | |||
| Volume | 304,463 | |||||
| (NASDAQ: TVTX) | Delayed: 27.24 -0.07 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.31 | 52 Week High | $ | |||
| Open | $26.61 | 52 Week Low | $ | |||
| Day High | $27.40 | P/E | N/A | |||
| Day Low | $26.43 | EPS | $ | |||
| Volume | 1,433,538 | |||||
